Pathway analysis of breast cancer genome-wide association study highlights three pathways and one canonical signaling cascade.
Genome-wide association studies (GWAS) focus on relatively few highly significant loci, whereas less attention is given to other genotyped markers. Using pathway analysis to study existing GWAS data may shed light on relevant biological processes and illuminate new candidate genes. We applied a pathway-based approach to the breast cancer GWAS data of the National Cancer Institute (NCI) Cancer Genetic Markers of Susceptibility project that includes 1,145 cases and 1,142 controls. Pathways were retrieved from three databases: KEGG, BioCarta, and NCI Protein Interaction Database. Genes were represented by their most strongly associated SNP, and an enrichment score reflecting the overrepresentation of gene-based association signals in each pathway was calculated by using a weighted Kolmogorov-Smirnov procedure. Finally, hierarchical clustering was used to identify pathways with overlapping genes, and clusters with an excess of association signals were determined by the adaptive rank-truncated product (ARTP) method. A total of 421 pathways containing 3,962 genes was included in our study. Of these, three pathways (syndecan-1-mediated signaling, signaling of hepatocyte growth factor receptor, and growth hormone signaling) were highly enriched with association signals [P(ES) < 0.001, false discovery rate (FDR) = 0.118]. Our clustering analysis revealed that pathways containing key components of the RAS/RAF/mitogen-activated protein kinase canonical signaling cascade were significantly more likely to have an excess of association signals than expected by chance (P(ARTP) = 0.0051, FDR = 0.07). These results suggest that genetic alterations associated with these three pathways and one canonical signaling cascade may contribute to breast cancer susceptibility.
Menashe
Idan
I
Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, Bethesda, MD20852-7244, USA. menashei@mail.nih.gov
Maeder
Dennis
D
Garcia-Closas
Montserrat
M
Figueroa
Jonine D
JD
Bhattacharjee
Samsiddhi
S
Rotunno
Melissa
M
Kraft
Peter
P
Hunter
David J
DJ
Chanock
Stephen J
SJ
Rosenberg
Philip S
PS
Chatterjee
Nilanjan
N
D000465:Algorithms; D001943:Breast Neoplasms / Q000235:genetics*; D005260:Female; D053263:Gene Regulatory Networks; D020022:Genetic Predisposition to Disease; D055106:Genome-Wide Association Study / Q000379:methods*; D006801:Humans; D008957:Models, Genetic; D051497:Receptor, Fibroblast Growth Factor, Type 2 / Q000235:genetics; D015398:Signal Transduction
C496353:FGFR2 protein, human; D051497:Receptor, Fibroblast Growth Factor, Type 2
Nat Rev Cancer. 2003 Jan;3(1):11-22
12509763
Nat Genet. 2006 Nov;38(11):1239-41
17033622
Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4340-5
18326623
Nat Genet. 2006 Aug;38(8):873-5
16832357
Cell. 2002 Jan 25;108(2):171-82
11832208
Science. 2002 Jun 21;296(5576):2225-9
12029063
Oncogene. 2008 Sep 18;27(41):5477-85
18794882
Nature. 2007 Jun 28;447(7148):1087-93
17529967
Nat Genet. 2007 Jul;39(7):870-4
17529973
Nature. 1995 Dec 21-28;378(6559):789-92
8524414
Nat Genet. 2007 Feb;39(2):165-7
17200668
Lancet. 2001 Oct 27;358(9291):1389-99
11705483
Nat Genet. 2002 May;31(1):55-9
11967536
Oncogene. 2006 Mar 2;25(9):1408-12
16247452
Breast Cancer Res Treat. 2007 Sep;104(3):233-48
17082888
Genet Epidemiol. 2009 Dec;33(8):700-9
19333968
Cancer Lett. 2005 Jul 8;225(1):1-26
15922853
Science. 1990 Nov 30;250(4985):1233-8
1978757
Crit Rev Oncol Hematol. 2000 Jan;33(1):1-6
10714958
Bioinformatics. 2003 Feb 12;19(3):368-75
12584122
Nat Genet. 2000 Dec;26(4):411-4
11101836
N Engl J Med. 2000 Jul 13;343(2):78-85
10891514
Breast Cancer Res. 2007;9(1):R8
17244359
Oncogene. 2002 Dec 16;21(58):8981-93
12483514
Am J Hum Genet. 2007 Dec;81(6):1278-83
17966091
Am J Hum Genet. 2009 Mar;84(3):399-405
19249008
Hum Mol Genet. 2009 Jun 1;18(11):2078-90
19286671
Genet Epidemiol. 2009 Jul;33(5):419-31
19235186
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
16199517
Nat Genet. 2009 May;41(5):579-84
19330030
Nat Genet. 2009 Mar;41(3):324-8
19219042
Science. 1994 Oct 7;266(5182):66-71
7545954
Nat Genet. 1996 May;13(1):114-6
8673088
J Natl Cancer Inst. 1997 Feb 19;89(4):287-93
9048832
Cytokine Growth Factor Rev. 2002 Feb;13(1):41-59
11750879
Oncology. 2004;67(1):11-8
15459490